BIO RAD Labs Inc
BIONASDAQStock · Data from SEC EDGAR 13F · Held by 8 of 87 tracked investors
BIO RAD Labs Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation22
- Growth24
- Profitability58
- Quality53
- Debt100
- Stability50
- ✓It has more cash than debt.
- !Revenue fell 2.7% a year over 3 years.
- !The stock is expensive: you pay 48.3 USD for 1 USD of annual earnings.
- !The analysts' average target is 12% below the price.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveFor 1 USD of annual earnings you pay 48.3 USD. Based on next year's estimates 39.1 USD.
- P/E
- 48.3×
- P/S
- 3.9×
- EV/EBITDA
- 22.0×
Is the company growing?
ShrinkingRevenue over 3 years grew -2.7% a year. Last year -0.1%.
Does it make money?
GoodEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 4 Aug 2026 | 2.62 | 2.34 | +12% |
| Mar 2026 | 30 Apr 2026 | 1.89 | 2.77 | -31.8% |
| Dec 2025 | 12 Feb 2026 | 2.51 | 2.57 | -2.3% |
| Sep 2025 | 29 Oct 2025 | 2.26 | 2.30 | -1.7% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart BIO
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
8JR John Rogers Ariel Investments | 2.39% |
JG Joel Greenblatt Gotham Asset Management | 0.11% |
MG Mario Gabelli GAMCO Investors | 0.07% |
CA Cliff Asness AQR Capital Management | 0.02% |
PT Paul Tudor Jones Tudor Investment Corp | 0.01% |
KF Ken Fisher Fisher Investments | 0.01% |
Šn Švýcarská národní banka Swiss National Bank | 0.01% |
Ns Norský státní fond Norges Bank | 0% |
Frequently asked questions
How much is BIO RAD Labs Inc (BIO) stock?
BIO RAD Labs Inc shares trade at $380.99, +2.30% over the last trading day. The price is delayed.
What is the market cap of BIO RAD Labs Inc?
The market cap of BIO RAD Labs Inc is about $10.2B and its price-to-earnings ratio (P/E) is 48.3.
Which big investors hold BIO RAD Labs Inc?
According to the latest 13F filings, 8 of 87 tracked investors hold BIO RAD Labs Inc, for example John Rogers, Joel Greenblatt, Mario Gabelli.
When will BIO RAD Labs Inc report its next results?
The next earnings report of BIO RAD Labs Inc is expected on 4 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.